Adma Biologics Inc (ADMA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -82.342 | -66.451 | -66.781 | -44.709 | -45.255 | -29.611 | -21.099 | -8.334 |
Return on Equity (%) | 1073.728 | -243.946 | -218.774 | -210.078 | -132.378 | -62.46 | -44.962 | -19.666 |
Return on Invested Capital (%) | -132.515 | -85.64 | -88.43 | -49.579 | -44.947 | -28.052 | -14.808 | 8.112 |
Operating Margin (%) | -162.049 | -177.817 | -354.56 | -133.858 | -151.026 | -72.386 | -30.26 | -1.244 |
Net Profit Margin (%) | -183.05 | -192.254 | -387.077 | -164.5 | -179.413 | -88.517 | -42.772 | -10.936 |
Book Value Per Share | -0.148 | 0.511 | 0.193 | 0.255 | 0.674 | 0.638 | 0.617 | 0.539 |
Earnings Per Share | -0.649 | -0.7 | -1.035 | -0.631 | -0.62 | -0.336 | -0.276 | -0.116 |
Cash Per Share | 0.33 | 0.69 | 0.358 | 0.35 | 0.458 | 0.24 | 0.362 | 0.211 |
Working Capital Per Share | 0.347 | 0.86 | 0.549 | 0.938 | 1.096 | 0.837 | 0.967 | 0.852 |
Operating Profit Per Share | 0.159 | -0.079 | -0.356 | -0.101 | -0.13 | 0.028 | 0.174 | 0.397 |
EBIT Per Share | -0.649 | -0.7 | -1.035 | -0.631 | -0.62 | -0.336 | -0.276 | -0.116 |
EBITDA Per Share | -0.649 | -0.7 | -1.035 | -0.631 | -0.62 | -0.336 | -0.276 | -0.116 |
Free Cash Flow Per Share | -0.662 | -0.7 | -1.056 | -0.624 | -0.548 | -0.299 | -0.247 | -0.13 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 12,89M | 45,32M | 46,35M | 59,32M | 104,9M | 195,81M | 221,82M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 221,82M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -1.184 | N/A | N/A | N/A | 27.078 | N/A | N/A |
Net Profit Margin (%) | N/A | -11.929 | N/A | N/A | N/A | 21.748 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,99B |
Ratio cours/bénéfice | -141,26 |
Ratio prix/ventes | 15,45 |
Ratio prix/liquidités | 77,72 |
Ratio prix/valeur comptable | 29,51 |
Rendement de dividende | - |
Actions en circulation | 236,39M |
Volume moyen (1 semaine) | 2,33M |
Volume moyen (1 mois) | 2,53M |
Variation sur 52 semaines | 227,27% |
Plus haut sur 52 semaines | 23,64 |
Plus bas sur 52 semaines | 5,02 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales